To medicinalaktier stod for de store historier på det danske marked mandag. Det var den amerikanske storbank JPMorgan, som ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Storbanken har en 'overvægt'-anbefaling på Novo -aktien, hvilket betyder, at de ser positivt på udviklingen og anbefaler, at ...

Novo Nordisk (NVO) has released an update. Novo Nordisk announced that its board members and executives have sold a significant volume of ...

For de mange tusinde danskere der ejer Novo Nordisk-aktier har det været et særdeles hårdt efterår at kigge på aktiekursen.

Novo Nordisk ( (NVO) ) has released its Q3 earnings. Here is a breakdown of the information Novo Nordisk presented to its investors. Novo ...

Novo Nordisk is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The maker of blockbuster weight-loss drugs Wegovy and Ozempic ...

After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its ...

Novo Nordisk's sales growth next year could be in the high teens in percentage terms, Chief Financial Officer Karsten Munk ...

Novo Nordisk on Wednesday nudged higher its outlook for the year as the drugmaker registered another quarter of strong sales of its weight-loss drugs.

Novo Nordisk-aktien skyder til vejrs ovenpå et regnskab, hvor frygten for en Wegovy-skuffelse blev gjort til skamme Et overskud på 27,3 milliarder kroner. Og måske endnu vigtigere en fremgang i salget ...

Tesla-aktien banker op – Musk kan tjene 150 milliarder på Trump-sejr Tesla-aktien banker op – Musk kan tjene 150 milliarder ...